January 2012

A recent study published in the journal BioMedCentral Pharmacology aimed to evaluate potential health risks posed to users of hormonal contraceptives containing drospirenone, such as YAZ®.

In this report, titled “The association between drospirenone and hyperkalemia: a comparative-safety study” a team of researchers led by Dr. ST Bird studied 1,148,183 women, and